Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study-Reference-Cited by-同舟云学术

Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study

Published:2021-02 Issue:2 Volume:104 Page:242-249
ISSN:0738-3991
Container-title:Patient Education and Counseling
language:en
Short-container-title:Patient Education and Counseling

Author:

Meagher Karen M.,Curtis Susan H.,Borucki Sarah,Beck Annika,Srinivasan Tarika,Cheema Amal,Sharp Richard R.

Funder

Mayo Clinic

Publisher

Elsevier BV

Subject

General Medicine

Reference71 articles.

1. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a national Heart, Lung, and Blood Institute working group;Fabsitz;Circ. Cardiovasc. Genet.,2010

2. Engineering, and medicine; health and medicine division; Board on health sciences policy; Committee on the return of individual-specific research results generated in research laboratories;National Academies of Sciences,2018

3. Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy;Bredenoord;Hum. Mutat.,2011

4. Pharmacogenomics and precision medicine;Kisor,2019

5. Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing;Tuteja;Per. Med.,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis;The Pharmacogenomics Journal;2023-11

2. Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL);Journal of Personalized Medicine;2022-08-29

3. Attitudes on pharmacogenomic results as secondary findings among medical geneticists;Pharmacogenetics and Genomics;2022-08-22

4. A clinician’s guide for counseling patients on results of a multigene pharmacogenomic panel;American Journal of Health-System Pharmacy;2022-07-25

5. A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling;Journal of Personalized Medicine;2022-03-09